A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia

A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia

Background Resembling acute promyelocytic leukemia (APL) is a unique subtype of APL who sharing clinical, morphological, and immunophenotypic features with typical APL, but lacking evidence of PML-RARA fusion gene and usually insensitive to arsenic trioxide (ATO) and all-trans retinoic acid (ATRA)....

Full description

Bibliographic Details
Main Authors:	Yang Song, Jiangxue Hou, Li Wan, Kaiqi Liu, Chunlin Zhou, Shuning Wei, Guangji Zhang, Dong Lin, Yan Li, Qiuyun Fang, Yuntao Liu, Benfa Gong, Xiaoyuan Gong, Ying Wang, Hui Wei, Jianxiang Wang, Yingchang Mi
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	Hematology
Subjects:	RARG-HNRNPM RNA-seq resembling acute promyelocytic leukemia fusion gene all-trans retinoic acid arsenic trioxide
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2022.2066825

Similar Items

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
by: Wenjing Ding, et al.
Published: (2023-01-01)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
by: Junmei Zhao, et al.
Published: (2022-09-01)

Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation
by: Danyang Wu, et al.
Published: (2023-12-01)

Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia
by: Zhichen Wei, et al.
Published: (2024-09-01)

Acute Promyelocytic Leukemia: Simplifying Treatment in a Resource Poor Setting
by: Rohan Bhise, et al.
Published: (2021-10-01)

HnRNPM modulates alternative splicing in germ cells by recruiting PTBP1
by: Peng Lv, et al.
Published: (2025-01-01)

High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation
by: Lin Xiu, et al.
Published: (2022-11-01)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Superiority of anthracycline‐free treatment in standard‐risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis
by: Kane Langdon, et al.
Published: (2024-03-01)

The bovine leukemia virus-derived long non-coding RNA AS1-S binds to bovine hnRNPM and alters the interaction between hnRNPM and host mRNAs
by: Kiyohiko Andoh, et al.
Published: (2023-10-01)

A Patient with Acute Promyelocytic Leukemia Treated with Isotretinoin: A Case Report
by: Ilja Goldin, et al.
Published: (2024-10-01)

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia
by: Xiao Liu, et al.
Published: (2023-07-01)

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
by: Riccardo Masetti, et al.
Published: (2023-04-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM
by: Nandini Ramesh, et al.
Published: (2020-08-01)

Acute promyelocytic leukemia. State of the art
by: Leonardo Mejía-Buriticá, et al.
Published: (2021-01-01)

Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review
by: Mehdi Mohammadi Kanesbi, et al.
Published: (2020-04-01)

Leucemia promielocítica de reciente diagnóstico. Tratamiento con trióxido de arsénico de producción nacional (Arsenin®)
by: Carlos Hernández Padrón, et al.

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2020-01-01)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01)

Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia
by: Xavier Thomas
Published: (2019-02-01)

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
by: Jose Tinajero, et al.
Published: (2022-01-01)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
by: Francesco Autore, et al.
Published: (2021-07-01)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
by: Damla Ortaboz, et al.
Published: (2023-03-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

C. elegans SUP-46, an HNRNPM family RNA-binding protein that prevents paternally-mediated epigenetic sterility
by: Wendy L. Johnston, et al.
Published: (2017-07-01)

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
by: Jaime Sanz, et al.
Published: (2021-03-01)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
by: Dominic LaBella, et al.
Published: (2022-08-01)

Risk factors for a differentiation syndrome in patients with acute promyelocytic leukemia
by: A. A. Semenova, et al.
Published: (2023-09-01)

First report of acute promyelocytic leukemia in a patient with Wilson’s disease: contemporary discussion of a management challenge
by: Zainab AlDawood, et al.
Published: (2023-12-01)

Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report
by: Yan H, et al.
Published: (2021-06-01)

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia
by: Xiaodong Liu, et al.
Published: (2023-04-01)

The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemia
by: Kai Shen, et al.
Published: (2025-02-01)

Massive pulmonary embolism at the onset of acute promyelocytic leukemia
by: Federica Sorà, et al.
Published: (2016-07-01)

Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
by: S. Venkatesan, et al.
Published: (2015-01-01)

Cytogenetics and FISH negative cryptic acute promyelocytic leukemia with CD56 expression
by: Jhansi Rani Arumugam, et al.
Published: (2021-01-01)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
by: Jiaojiao Yuan, et al.
Published: (2023-03-01)

ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report
by: Laura Pardo Gambarte, et al.
Published: (2022-04-01)

A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes
by: Setsuki Isono, et al.
Published: (2013-02-01)

Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol
by: E N Parovichnikova, et al.
Published: (2013-07-01)